Geneviève Durrieu

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 8

Top Topics

Parkinson Disease

Low Density Lipoprotein

Top Venues

Fundamental & clinical pharmacology

Pharmacoepidemiology and drug safety

Paediatric drugs

This page only lists publications with an associated author ORCID identifier.

Publications

Madlen Gazarian, Daniel B Horton, Bruce C Carleton, Alan C Kinlaw, Greta Bushnell A, Angela S Czaja, Geneviève Durrieu, Emily F Gorman, Lina Titievsky, Julie M Zito, Jonathan L Slaughter, Susan dosReis
Optimizing therapeutic decision-making for off-label medicines use: a scoping review and consensus recommendations for improving practice and research. Pharmacoepidemiology and drug safety (2023)
Madlen Gazarian, Daniel B Horton, Bruce C Carleton, Alan C Kinlaw, Greta Bushnell A, Angela S Czaja, Geneviève Durrieu, Emily F Gorman, Lina Titievsky, Julie M Zito, Jonathan L Slaughter, Susan dosReis
Optimizing therapeutic decision-making for off-label medicines use: a scoping review and consensus recommendations for improving practice and research. Pharmacoepidemiology and drug safety (2023)
Jean-Louis Montastruc, Geneviève Durrieu
Amiodarone and Parkinsonism: a pharmacovigilance study. Fundamental & clinical pharmacology 35 (4) (2020)
Cécile Conte, Vanessa Rousseau, Charlotte Vert, François Montastruc, Jean-Louis Montastruc, Geneviève Durrieu, Pascale Olivier
Adverse drug reactions of statins in children and adolescents: a descriptive analysis from VigiBase, the WHO global database of individual case safety reports. Fundamental & clinical pharmacology 34 (4) (2020)
Adrien Gainville, Vanessa Rousseau, Florentia Kaguelidou, Marie Boyer Gervoise, Joëlle Michot, Véronique Pizzoglio-Bellaudaz, Leila Chebane, Alexandra Weckel, Jean-Louis Montastruc, Geneviève Durrieu
Drug-Induced Hearing Loss in Children: An Analysis of Spontaneous Reports in the French PharmacoVigilance Database. Paediatric drugs 23 (1) (2020)
Fabien Despas, Vanessa Rousseau, Margaux Lafaurie, Claire De Canecaude, Geneviève Durrieu, Haleh Bagheri, François Montastruc, Jean-Louis Montastruc
Are lipid-lowering drugs associated with a risk of cataract? A pharmacovigilance study. Fundamental & clinical pharmacology 33 (6) (2019)
Geneviève Durrieu, Quentin Dardonville, Michel Clanet, Jean-Louis Montastruc
Cervical dysplasia in a patient with multiple sclerosis treated with natalizumab. Fundamental & clinical pharmacology 33 (1) (2018)
François Montastruc, Justine Benevent, Vanessa Rousseau, Geneviève Durrieu, Agnès Sommet, Jean-Louis Montastruc
Risk of diabetes with fibrates and statins: a pharmacoepidemiological study in VigiBase®. Fundamental & clinical pharmacology 33 (1) (2018)